Chris Tauer
Chief Financial Officer
Pharmaceutical Sciences
beryllium discovery
United States of America
Biography
I started working at MediChem Life Sciences, a drug discovery and technology company, in a finance role when I graduated from college. deCODE Genetics acquired MediChem three years later, and I stayed on as vice president of finance at the Icelandic company’s U.S. office. Later, I became chief financial officer of Emerald Bio when the company spun out from deCODE in 2009
Research Interest
Pharmaceutical Sciences